Research and Markets: Global Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Pipeline Insights Report 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/xsbps7/clostridium) has announced the addition of the "Clostridium Difficile Infections (Clostridium Difficile Associated Disease)-Pipeline Insights" report to their offering.

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Pipeline Insights provides the in-depth analysis of the pipeline assets across the Clostridium Difficile Infections (Clostridium Difficile Associated Disease). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Pipeline Insights Report covers the Clostridium Difficile Infections (Clostridium Difficile Associated Disease) pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Clostridium Difficile Infections (Clostridium Difficile Associated Disease) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Clostridium Difficile Infections (Clostridium Difficile Associated Disease).

Scope

- The report provides a Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Clostridium Difficile Infections (Clostridium Difficile Associated Disease) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease) and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/xsbps7/clostridium

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals